about
Pituitary adenylate cyclase-activating polypeptide attenuates streptozotocin-induced apoptotic death of RIN-m5F cells through regulation of Bcl-2 family protein mRNA expressionA β-peptide agonist of the GLP-1 receptor, a class B GPCR.Vasoactive intestinal peptide-null mice demonstrate enhanced sweet taste preference, dysglycemia, and reduced taste bud leptin receptor expression.Xenin-25 potentiates glucose-dependent insulinotropic polypeptide action via a novel cholinergic relay mechanism.Proteomics of rat hypothalamus, hippocampus and pre-frontal/frontal cortex after central administration of the neuropeptide PACAP.Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.Cell signalling in insulin secretion: the molecular targets of ATP, cAMP and sulfonylurea.Biological pathway-based genome-wide association analysis identified the vasoactive intestinal peptide (VIP) pathway important for obesityChitosan-decorated selenium nanoparticles as protein carriers to improve the in vivo half-life of the peptide therapeutic BAY 55-9837 for type 2 diabetes mellitusLack of TRPM2 impaired insulin secretion and glucose metabolisms in mice.Epigenetic modulation of type-1 diabetes via a dual effect on pancreatic macrophages and β cells.VIP and PACAP: recent insights into their functions/roles in physiology and disease from molecular and genetic studies.Emerging Role of PACAP as a New Potential Therapeutic Target in Major Diabetes Complications.Taste perception, associated hormonal modulation, and nutrient intakeHigh glucose and free fatty acids induce beta cell apoptosis via autocrine effects of ADP acting on the P2Y(13) receptor.Direct autocrine action of insulin on β-cells: does it make physiological sense?A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects.Trophic effects of PACAP on pancreatic islets: a mini-review.Structural aspects of gut peptides with therapeutic potential for type 2 diabetes.Potential role of skeletal muscle glucose metabolism on the regulation of insulin secretion.Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes.Stapled Vasoactive Intestinal Peptide (VIP) Derivatives Improve VPAC2 Agonism and Glucose-Dependent Insulin Secretion.beta-Arrestin 1 is required for PAC1 receptor-mediated potentiation of long-lasting ERK1/2 activation by glucose in pancreatic beta-cells.MafA-Controlled Nicotinic Receptor Expression Is Essential for Insulin Secretion and Is Impaired in Patients with Type 2 Diabetes.Suprachiasmatic Nucleus Neuropeptides and Their Control of Endogenous Glucose Production.Vasoactive intestinal peptide is a local mediator in a gut-brain neural axis activating intestinal gluconeogenesis.Effect of VPAC1 Blockade on Adipose Tissue Formation and Composition in Mouse Models of Nutritionally Induced Obesity.VPAC2 receptor expression in human normal and neoplastic tissues: evaluation of the novel MAB SP235.Neuronal signals regulate obesity induced β-cell proliferation by FoxM1 dependent mechanism.
P2860
Q28571018-A81D8948-2CD0-455D-AE8F-F7A3F1F7A981Q33553641-C13AEA45-418C-434A-87C2-878738FF63B7Q33803426-9C314177-2EAB-415D-ACF0-B2D184FA3B5BQ33924273-15F3EA28-93E4-4296-AF0A-7A550AD0F757Q33936997-0DDB7CCF-C343-4A06-A085-A6C4D1A39CE7Q34238010-B6A3890E-0B89-4E8F-8D8D-F1050FED91DEQ34272586-0388525F-5FD0-4008-9F26-120BC8915058Q34307289-BADED8EA-B24A-4459-AE05-A3D8A6A1E8F3Q34394374-71E3C71B-E542-4DF7-B862-73E3F6F59EC3Q34448620-4AAFE62A-BEE0-4094-99AA-F5C1D32FBF6DQ34729508-6D476721-3C8C-476C-8F29-9CCDC09C0780Q34788079-4C786236-06EF-484C-AC3C-0146593A65F0Q35657065-08B79386-9BFA-4119-A975-A03E5A934473Q36014572-36DAE7C3-6161-4904-9730-A9BAD4596E3BQ36598549-E8F2302D-EAEC-4A78-ADD0-1487456505D5Q37014947-3EC13AD1-EF3E-440F-AFE1-B949518ED05CQ37722693-4FE33401-E7DC-46B6-BB8A-2E3023FEED10Q37774288-93C3C61A-283A-4E30-859F-251BB9163090Q38071991-74ABC714-44EC-4A1B-AD53-74B7DBBC65DDQ38195143-1C0B3319-08CA-4950-86E8-4A1467602494Q38203645-270EF72E-2925-4920-A5EC-484CAB0FAF68Q39771664-1EB1850C-3C5F-4DCA-A47D-A7766B9251D6Q39906419-6A888990-A3D2-4DDE-89B0-D7B2F46D024BQ39976882-E4CE700E-52D8-4980-AE7B-EA48A1DC9CFEQ40082525-6E54F5AC-4896-405F-B73C-7B57BCAA7C5CQ41586304-2A81CDAF-7330-4C27-BB72-A7907B771BD6Q41976707-8268EDB9-E513-4DBB-B51D-0E1BC5C8AF8AQ42573452-84F5D58B-5687-4AAD-8112-7FA61C4A8F24Q47105510-6F192152-763F-4CD3-BC4D-23BD8BD5D34B
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Role of VIP and PACAP in islet function.
@ast
Role of VIP and PACAP in islet function.
@en
type
label
Role of VIP and PACAP in islet function.
@ast
Role of VIP and PACAP in islet function.
@en
prefLabel
Role of VIP and PACAP in islet function.
@ast
Role of VIP and PACAP in islet function.
@en
P1433
P1476
Role of VIP and PACAP in islet function.
@en
P2093
Maria Sörhede Winzell
P304
P356
10.1016/J.PEPTIDES.2007.04.024
P50
P577
2007-05-06T00:00:00Z